Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3- (5-chloro-2-cyanophenoxy) -2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3 (2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs

Ishimori, T.; Gotanda, K.; Sasaki, T.; Shinbo, A.; Asano, H.; Miyazawa, K.; Miyasaka, K.

Arzneimittel-Forschung 44(5): 583-588

1994

ISSN/ISBN: 0004-4172
PMID: 7912931
Document Number: 432909
The cardiovascular effects of 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2- hydroxypropylamino]-2-methylpropylamino]phenyl]-4,5-dihydro- 5-methyl-3(2H) pyridazinone monoethyl maleate (salt) (TZC-5665, CAS 114856-47-2) and its main metabolite in human, M-2, were investigated in isolated atrial and ventricular muscles of guinea pigs and dogs, in guinea pig atrial and right ventricular papillary muscles. TZC-5665 showed negative chronotropic and inotropic effects, whereas M-2 showed a potent positive inotropic effect with a slight positive chronotropic effect. The positive inotropic effect of M-2 was not modified by phentolamine, propranolol and cimetidine, but completely depressed by carbachol. In blood-perfused dog heart preparations, M-2 increased the contractile force and coronary blood flow of paced papillary muscles and sinus rate. Although TZC-5665 scarcely affected the contractile force and sinus rate, it increased coronary blood flow. TZC-5665 scarcely affected atrio-ventricular (AV) conduction time, whereas M-2 slightly shortened AV conduction time. The rate of ventricular automaticity was slightly increased by M-2, but suppressed by TZC-5665 at higher doses. TZC-5665 showed a non-selective beta-adrenoceptor blocking activity comparable to that of propranolol in guinea-pig atrial and tracheal preparations. In enzyme preparations, TZC-5665 and M-2 were more potent and selective inhibitors of phosphodiesterase (PDE) III than milrinone. Combination of beta-adrenoceptor blocking effect of TZC-5665 and positive inotropic effect of M-2 could be useful in the treatment of congestive heart failure by mutual prevention of undesirable effects.

Document emailed within 1 workday
Secure & encrypted payments

Asami, Y.; Otsuka, M.; Hirohashi, T.; Inaba, S.; Yamamoto, H. 1974: The synthesis and pharmacology of a novel benzodiazepine derivative, 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one(ID-540) Arzneimittel-Forschung 24(10): 1563-1568
Igawa, O.; Kotake, H.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Mashiba, H. 1989: Effects of trimebutine maleate on electrical activities of isolated mammalian cardiac preparations Journal of Pharmacy and Pharmacology 41(5): 311-315
Herzig, J.W.; Chiesi, M.; Depersin, H.; Grüninger, S.; Hasenfuss, G.; Kubalek, R.; Leutert, T.; Pieske, B.; Pioch, K.; Wenk, P.; Holubarsch, C. 1996: Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips Arzneimittel-Forschung 46(6): 586-593
Harik, S.I.; Schmidley, J.W.; Iacofano, L.A.; Blue, P.; Arora, P.K.; Sayre, L.M. 1987: On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat Journal of Pharmacology and Experimental Therapeutics 241(2): 669-676
Ohhara, H.; Sawada, K.; Ogawa, T.; Takeda, M.; Igarashi, T. 1992: Effects of the new cardiotonic agent loprinone hydrochloride (E-1020) on left ventricular diameter in normal and experimental heart failure dogs and its action potential characteristics in isolated guinea pig cardiac muscles and sinus nodes Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 99(6): 421-433
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Fukuda, T.; Itoh, K.; Nose, T. 1981: Antiulcerogenic action of 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one (KB-509), a new benzodiazepine derivative Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 77(3): 273-280
Singh, P.I.; Khurana, I.; Maini, B.K. 1983: A study of vagal tone and cardiac effects of unilateral versus bilateral vagal stimulation in dogs, cats, rabbits and guinea pigs Indian Journal of Medical Sciences 37(3): 45-48
Knowles, J.A.; Ruelius, H.W. 1972: Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection Arzneimittel-Forschung 22(4): 687-692
Thomas, M.; Stephen, P.M. 1983: Effect of histamine H-2 blocker - metiamide - on the isolated atrial preparations of rabbits & guinea pigs Indian Journal of Experimental Biology 21(2): 84-87
Boissier, J.R.; Simon, P.; Zaczinska, M.; Fichelle, J. 1972: Experimental psychopharmacologic study of a new psychotropic drug, 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine Therapie 27(2): 325-338
Vittorio, F.; Santagati, N.A.; Lancetta, T.; Duro, F.; Arrigo Reina, R.; Cosentino, C. 1984: Alkyl and aryl derivatives of isoquinoline. II. Synthesis and pharmacologic activity of dialkylaminoalkyl esters of 1-chloro-3-carboxy-4-methylisoquinoline and the corresponding 4-phenyl derivative Il Farmaco; Edizione Scientifica 39(3): 217-228
Pfeifer, S.; Bornschein, I.; Gehrke, A. 1977: Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent Die Pharmazie 32(10): 587-592
Kriska, M.; Kovalcik, V. 1976: Reactivity of the isolated ductus arteriosus of guinea pigs and dogs during a short prenatal and postnatal period Bratislavske Lekarske Listy 65(6): 620-624
Bruno, O.; Ranise, A.; Bondavalli, F.; Schenone, P.; D'Amico, M.; Filippelli, A.; Filippelli, W.; Rossi, F. 1993: 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities Farmaco 48(7): 949-966
Jiang, H.-N.; Qu, J.-M.; He, L.-X.; Chen, X.-H.; Pan, J.; Li, L.; Zhu, D.-N.; Cao, Y.-X.; Shen, L.-L. 2008: Effects of N(omega)-nitro-L-arginine methyl ester and aminoguanidine on lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs Chinese Medical Journal 121(17): 1693-1697
Brzozowski, Z.; Sławiński, J.; Angielski, S.; Szczepańska-Konkiel, M. 1985: Derivatives of 1,1-dioxo-1,4,2-benzodithiazine. III. Synthesis and diuretic properties of 3-(R,R1-phenyl)amino-6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiaz ine s Acta Poloniae Pharmaceutica 42(4): 313-318
Lan, S.J.; Chando, T.J.; Cohen, A.I.; Weliky, I.; Schreiber, E.C. 1973: Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(4): 619-627
El-Sadek, S.E.; Ibrahim, S.S.; Abdel-Salam, S.A. 1989: Effect of chloropheniramine maleate on liver and kidney functions as well as blood count of guinea pigs Archiv für Experimentelle Veterinarmedizin 43(2): 249-253
Xiao, J.G.; Li, X.D.; Liu, T.P. 1987: Electrophysiological effects of vanilol on isolated papillary muscles of guinea pigs and atrioventricular conduction in rabbits Zhongguo Yao Li Xue Bao 8(1): 40-44